Finance

Beta
Ask
Lists
SPTX:NASDAQ
Seaport Therapeutics Inc
$18.79
+4.45%
(+0.80) 1D
Jun 23, 12:33:22 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPTX...
Open
$17.74
High
$19.19
Low
$17.74
Mkt. cap
988.71M
Avg. vol.
262.57K
Volume
80.44K
52-wk high
$23.00
52-wk low
$14.85
No. of employees
58
Open
$17.74
High
$19.19
Low
$17.74
Mkt. cap
988.71M
Avg. vol.
262.57K
Volume
80.44K
52-wk high
$23.00
52-wk low
$14.85
No. of employees
58
News stories
From sources across the web
About Seaport Therapeutics Inc
CEODaphne Zohar
Employees58
Founded2024
Headquarters-
SectorPharmaceutical industry
Websiteseaporttx.com
Analyst Ratings
Based on 4 analysts giving stock ratings to SPTX in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SPTX in the last 3 months.
Highest
Current $18.79
$42.00 (+123.52%)
Average
$35.50 (+88.93%)
Lowest
$30.00 (+59.66%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$30.00
+59.7%
06/09/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
$42.00
+123.5%
06/08/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$35.00
+86.3%
06/08/2026
Marc Goodman
Leerink Partners
Buy
Initiated
$35.00
+86.3%
05/27/2026
Last report
Jun 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$10.34 / -$3.88
-166.27%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10.53M
20.86M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.65M
6.11M
Operating expense
16.18M
26.98M
Total operating expenses
16.18M
26.98M
Operating income
-16.18M
-26.98M
Other non operating income
-9.00K
-46.00K
EBT including unusual items
-13.09M
-24.89M
EBT excluding unusual items
-13.09M
-24.89M
Income tax expense
31.00K
519.00K
Effective tax rate
-0.24%
-2.09%
Other operating expenses
-
-
Net income
-13.12M
-25.41M
Net profit margin
-
-
Earnings per share
-
-10.34
Interest and investment income
3.10M
2.13M
Interest expense
-
-
Net interest expenses
3.10M
2.13M
Depreciation and amortization charges
-
-
EBITDA
-16.15M
-26.95M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer